Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725.
2. Wahren-Herlenius M, Dorner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013;382(9894):819-31.
3. Oates JC. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity 2010;43(1):56-63.
4. Su YJ, Cheng TT, Chen CJ, Chiu WC, Chang WN, Tsai NW, Kung CT, Lin WC, Huang CC, Chang YT, Su CM, Chiang YF, Cheng BC, Lu CH. The association among antioxidant enzymes, autoantibodies, and disease severity score in systemic lupus erythematosus: comparison of neuropsychiatric and nonneuropsychiatric groups. Biomed Res Int 2014;2014:137231.
5. Chen PY, Chang CH, Hsu CC, Liao YY, Chen KT. Systemic lupus erythematosus presenting with cardiac symptoms. Am J Emerg Med 2014;32(9):1117-9.
6. Eudy A, Vines A, Dooley M, Cooper G, Parks C. Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus. Lupus 2014;23(14):1460-7.
7. Agmon-Levin N, Blank M, Paz Z, Shoenfeld Y. Molecular mimicry in systemic lupus erythematosus. Lupus 2009;18(13):1181-5.
8. Sebastiani GD, Galeazzi M. Infection--genetics relationship in systemic lupus erythematosus. Lupus 2009;18(13):1169-75.
9. Perez YG, Perez LC, Netto RC, Lima DS, Lima ES. Malondialdehyde and sulfhydryl groups as biomarkers of oxidative stress in patients with systemic lupus erythematosus. Rev Bras Reumatol 2012;52(4):658-60.
10. Taysi S, Gul M, Sari RA, Akcay F, Bakan N. Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 2002;40(7):684-8.
11. Gheita TA, Kenawy SA. Measurement of malondialdehyde, glutathione, and glutathione peroxidase in SLE patients. Methods Mol Biol 2014;1134:193-9.
12. Hassan SZ, Gheita TA, Kenawy SA, Fahim AT, El-Sorougy IM, Abdou MS. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 2011;14(4):325-31.
13. Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003;157(4):345-54.
14. Strecker D, Mierzecki A, Radomska K. Copper levels in patients with rheumatoid arthritis. Ann Agric Environ Med 2013;20(2):312-6.
15. Sahebari M, Abrishami-Moghaddam M, Moezzi A, Ghayour-Mobarhan M, Mirfeizi Z, Esmaily H, Ferns G. Association between serum trace element concentrations and the disease activity of systemic lupus erythematosus. Lupus 2014;23(8):793-801.
16. Yilmaz A, Sari RA, Gundogdu M, Kose N, Dag E. Trace elements and some extracellular antioxidant proteins levels in serum of patients with systemic lupus erythematosus. Clin Rheumatol 2005;24(4):331-5.
17. Lopez P, Mozo L, Gutierrez C, Suarez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003;12(11):860-5.
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25(11):1271-7.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502.
20. Gerard-Monnier D, Erdelmeier I, Regnard K, Moze-Henry N, Yadan JC, Chaudiere J. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 1998;11(10):1176-83.
21. Apak R, Guclu K, Ozyurek M, Karademir SE, Altun M. Total antioxidant capacity assay of human serum using copper(II)-neocuproine as chromogenic oxidant: the CUPRAC method. Free Radic Res 2005;39(9):949-61.
22. Salas-Salvado J, Rubio MA, Barbany M, Moreno B. [SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria]. Med Clin (Barc ) 2007;128(5):184-96.
23. Frostegard J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Horkko S, Witztum JL. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 2005;52(1):192-200.
24. Kurien BT, Scofield RH. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci 2003;73(13):1655-66.
25. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, Rokach J, Shigenaga MK et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005;38(6):698-710.
26. Delgado AJ, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 2002;46(10):2686-94.
27. Lozovoy MA, Simao AN, Panis C, Rotter MA, Reiche EM, Morimoto HK, Lavado E, Cecchini R, Dichi I. Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus 2011;20(12):1250-9.
28. Batuca JR, Ames PR, Amaral M, Favas C, Isenberg DA, Delgado AJ. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus. Rheumatology (Oxford) 2009;48(1):26-31.
29. Moroni G, Novembrino C, Quaglini S, De GR, Gallelli B, Uva V, Montanari V, Messa P, Bamonti F. Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Lupus 2010;19(1):65-72.
30. Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani MJ, Larijani B, Abdollahi M. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 2005;36(4):376-81.
31. Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, Esterbauer H, Siems WG. Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med 1997;23(3):357-60.
32. Serban MG, Balanescu E, Nita V. Lipid peroxidase and erythrocyte redox system in systemic vasculitides treated with corticoids. Effect of vitamin E administration. Rom J Intern Med 1994;32(4):283-9.
33. Suryaprabha P, Das UN, Ramesh G, Kumar KV, Kumar GS. Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids 1991;43(4):251-5.
34. Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B, Nagy J. Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 1997;22(1-2):161-8.
35. Gaitonde S, Samols D, Kushner I. C-reactive protein and systemic lupus erythematosus. Arthritis Rheum 2008;59(12):1814-20.
36. Enocsson H, Sjowall C, Kastbom A, Skogh T, Eloranta ML, Ronnblom L, Wettero J. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-alpha and a C-reactive protein gene variant. Arthritis Rheumatol 2014;66(6):1568-73.
Número de descargas:
5595
Número de visitas:
14800
Citas:
7
